Fingerprint
Dive into the research topics of 'A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma
André Goy, Francisco J. Hernandez-Ilzaliturri, Brad Kahl, Peggy Ford, Ewelina Protomastro, Mark Berger
Research output: Contribution to journal › Article › peer-review
46
Scopus
citations